Can fat maldigestion, trans fats, and phosphatidylcholine constraints lower long-chain omega-3 incorporation into membranes?

The systemic availability and cellular incorporation of long-chain omega-3 fatty acids (EPA and DHA) depend on a complex cascade of digestion, endogenous synthesis, and phospholipid remodeling.

Digestive and transport limitations

• Fat maldigestion: Exocrine pancreatic insufficiency, marked by low pancreatic lipase activity, impairs the hydrolysis of dietary triglycerides. Without adequate lipase, EPA and DHA cannot form the micelles necessary for enterocyte absorption, significantly blunting membrane incorporation. This barrier is clinically reversible via pancreatic enzyme replacement therapy (PERT).
• Phosphatidylcholine constraints: The hepatic phosphatidylethanolamine N-methyltransferase (PEMT) pathway preferentially generates DHA-rich phosphatidylcholine (DHA-PC) for systemic export to peripheral tissues. The PEMT rs7946 loss-of-function variant reduces enzymatic activity by approximately 30%, restricting endogenous DHA-PC synthesis and subsequently limiting DHA delivery to cell membranes.

Dietary and genetic competition

• Trans fat exposure: Industrial trans fatty acids, particularly elaidic acid, act as competitive inhibitors of $\Delta$-5 (FADS1) and $\Delta$-6 (FADS2) desaturases, blocking the upstream synthesis of EPA and DHA. Additionally, trans fats physically compete for finite sn-2 acyl slots during membrane phospholipid remodeling.
• ELOVL2 elongation dynamics: In contrast to the claim, the major T allele (TT genotype) of ELOVL2 rs3734398 represents highly efficient endogenous DHA elongation and higher baseline membrane levels. It is the minor C allele that impairs elongation, though its effects are bypassed by supplementing preformed marine omega-3s.

Bottom line

• Fat maldigestion, PEMT rs7946-driven phosphatidylcholine constraints, and trans fat exposure are scientifically validated or highly plausible barriers to membrane omega-3 incorporation. However, the claim regarding elongation is inaccurate; the ELOVL2 major allele (TT) preserves, rather than impairs, DHA elongation.